Adverse pathology and undetectable ultrasensitive prostate-specific antigen after radical prostatectomy: is adjuvant radiation warranted?-Reference-Cited by-同舟云学术

Adverse pathology and undetectable ultrasensitive prostate-specific antigen after radical prostatectomy: is adjuvant radiation warranted?

Published:2015-06-23 Issue:6 Volume:117 Page:897-903
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Simon Ross M.¹²,Howard Lauren E.¹³,Freedland Stephen J.⁴,Aronson William J.⁵⁶,Terris Martha K.⁷⁸,Kane Christopher J.⁹,Amling Christopher L.¹⁰,Cooperberg Matthew R.¹¹¹²¹³,Vidal Adriana C.⁴

Affiliation:

1. Duke Prostate Center; Division of Urology; Department of Surgery and Pathology; Duke University School of Medicine; Durham NC USA

2. Urology Section; Veterans Affairs Medical Center; Durham NC USA

3. Department of Biostatistics and Bioinformatics; Duke University School of Medicine; Durham NC USA

4. Department of Surgery; Division of Urology; Samuel Oschin Comprehensive Cancer Institute; Cedars-Sinai Medical Center; Los Angeles CA USA

5. Urology Section; Department of Surgery; Veterans Affairs Medical Center of Greater Los Angeles; Los Angeles CA USA

6. Department of Urology; University of California at Los Angeles Medical Center; Los Angeles CA USA

7. Urology Section; Division of Surgery; Veterans Affairs Medical Center; Augusta GA USA

8. Division of Urologic Surgery; Department of Surgery; Medical College of Georgia; Augusta GA USA

9. Division of Urology; Department of Surgery; University of California at San Diego Medical Center; San Diego CA USA

10. Department of Urology; Oregon Health and Science University; Portland OR USA

11. Department of Urology; University of California at San Francisco; San Francisco CA USA

12. Department of Epidemiology and Biostatistics; University of California at San Francisco; San Francisco CA USA

13. Urology Section; Department of Surgery; Veterans Affairs Medical Center; San Francisco CA USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.13182/fullpdf

Reference32 articles.

1. Management of biochemically recurrent prostate cancer after local therapy: evolving standards of care and new directions;Paller;Clin Adv Hematol Oncol,2013

2. Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens;Swindle;J Urol,2008

3. Pathologic findings at radical prostatectomy: risk factors for failure and death;Swanson;Urol Oncol,2007

4. Predictors of prostate-specific antigen progression among men with seminal vesicle invasion at the time of radical prostatectomy;Freedland;Cancer,2004

5. Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy;Blute;J Urol,2001

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Gleason score of the tumor at the positive surgical margin as a prognostic factor;Molecular and Clinical Oncology;2022-02-10

2. Robotic radical prostatectomy: analysis of midterm pathologic and oncologic outcomes: A historical series from a high-volume center;Surgical Endoscopy;2020-12-07

3. Long- versus short-term androgen deprivation therapy with high-dose radiotherapy for biochemical failure after radical prostatectomy: a randomized controlled trial;Future Oncology;2020-09

4. The impact of surgical margin status on prostate cancer-specific mortality after radical prostatectomy: a systematic review and meta-analysis;Clinical and Translational Oncology;2020-05-14

5. Positive surgical margin is associated with biochemical recurrence risk following radical prostatectomy: a meta-analysis from high-quality retrospective cohort studies;World Journal of Surgical Oncology;2018-07-03